---
title: "12 Health Care Stocks Moving In Tuesday's After-Market Session"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293389193.md"
description: "During Tuesday's after-market session, several healthcare stocks experienced significant volatility. Gainers included ENDRA Life Sciences (+10.8%), Apimeds Pharmaceuticals (+10.06%), and China Pharma Holding (+9.62%). Conversely, major losers featured Catheter Precision (-21.0%), Zhengye Biotechnology (-11.93%), and Dyne Therapeutics (-11.83%). The report highlights specific price movements and market capitalizations for these listed companies."
datetime: "2026-07-21T21:05:43.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293389193.md)
  - [en](https://longbridge.com/en/news/293389193.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293389193.md)
---

# 12 Health Care Stocks Moving In Tuesday's After-Market Session

### Gainers

-   **ENDRA Life Sciences** (NASDAQ:NDRA) shares rose 10.8% to $5.94 during Tuesday's after-market session. The market value of their outstanding shares is at $6.2 million.
-   **Apimeds Pharmaceuticals** (AMEX:APUS) shares rose 10.06% to $0.7. The company's market cap stands at $9.7 million.
-   **China Pharma Holding** (AMEX:CPHI) stock increased by 9.62% to $8.88. The company's market cap stands at $36.8 million.
-   **Adagio Medical Holdings** (NASDAQ:ADGM) stock increased by 9.23% to $0.48. The market value of their outstanding shares is at $11.3 million.
-   **Lexaria Bioscience** (NASDAQ:LEXX) shares increased by 8.34% to $0.6. The market value of their outstanding shares is at $14.8 million.
-   **Nexalin Technology** (NASDAQ:NXL) shares moved upwards by 5.92% to $0.51. The market value of their outstanding shares is at $10.8 million.

### Losers

-   **Catheter Precision** (AMEX:VTAK) shares fell 21.0% to $0.39 during Tuesday's after-market session. The market value of their outstanding shares is at $1.8 million.
-   **Zhengye Biotechnology** (NASDAQ:ZYBT) stock declined by 11.93% to $2.51. The company's market cap stands at $379.6 million.
-   **Dyne Therapeutics** (NASDAQ:DYN) stock declined by 11.83% to $21.0. The company's market cap stands at $3.8 billion.
-   **Pomdoctor** (NASDAQ:POM) stock declined by 11.21% to $0.8. The company's market cap stands at $102.5 million.
-   **Niki BioSolutions** (NASDAQ:NIKI) stock fell 9.31% to $8.67. The company's market cap stands at $71.9 million.
-   **First Tracks** (NASDAQ:TRAX) stock decreased by 8.51% to $34.19. The company's market cap stands at $1.2 billion. **See Also:** www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

### Related Stocks

- [NDRA.US](https://longbridge.com/en/quote/NDRA.US.md)
- [VTAK.US](https://longbridge.com/en/quote/VTAK.US.md)
- [APUS.US](https://longbridge.com/en/quote/APUS.US.md)
- [ZYBT.US](https://longbridge.com/en/quote/ZYBT.US.md)
- [DYN.US](https://longbridge.com/en/quote/DYN.US.md)
- [CPHI.US](https://longbridge.com/en/quote/CPHI.US.md)
- [ADGM.US](https://longbridge.com/en/quote/ADGM.US.md)
- [LEXX.US](https://longbridge.com/en/quote/LEXX.US.md)
- [NXL.US](https://longbridge.com/en/quote/NXL.US.md)
- [POM.US](https://longbridge.com/en/quote/POM.US.md)
- [NIKI.US](https://longbridge.com/en/quote/NIKI.US.md)
- [TRAX.US](https://longbridge.com/en/quote/TRAX.US.md)
- [29273B500.US](https://longbridge.com/en/quote/29273B500.US.md)
- [LEXXW.US](https://longbridge.com/en/quote/LEXXW.US.md)
- [NXLIW.US](https://longbridge.com/en/quote/NXLIW.US.md)

## Related News & Research

- [China Pharma Holdings Announces New Capital Raising Agreement](https://longbridge.com/en/news/293531766.md)
- [Dyne Therapeutics director Dirk Kersten disposes of 261,460 common shares worth $6.67 million](https://longbridge.com/en/news/294254633.md)
- [How investors can navigate the healthcare sector](https://longbridge.com/en/news/293960711.md)
- [Flyte Partners with LDV at The Maidstone to Elevate Luxury Travel to the Hamptons | VTAK Stock News](https://longbridge.com/en/news/294216437.md)
- [Dyne Therapeutics Upsized Equity Offering Strengthens Cash Runway](https://longbridge.com/en/news/293529976.md)